278 related articles for article (PubMed ID: 22014662)
1. The constitutively active Ah receptor (CA-AhR) mouse as a model for dioxin exposure - effects in reproductive organs.
Brunnberg S; Andersson P; Poellinger L; Hanberg A
Chemosphere; 2011 Dec; 85(11):1701-6. PubMed ID: 22014662
[TBL] [Abstract][Full Text] [Related]
2. Responsiveness of the adult male rat reproductive tract to 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure: Ah receptor and ARNT expression, CYP1A1 induction, and Ah receptor down-regulation.
Roman BL; Pollenz RS; Peterson RE
Toxicol Appl Pharmacol; 1998 Jun; 150(2):228-39. PubMed ID: 9653054
[TBL] [Abstract][Full Text] [Related]
3. Effects of aryl hydrocarbon receptor null mutation and in utero and lactational 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure on prostate and seminal vesicle development in C57BL/6 mice.
Lin TM; Ko K; Moore RW; Simanainen U; Oberley TD; Peterson RE
Toxicol Sci; 2002 Aug; 68(2):479-87. PubMed ID: 12151645
[TBL] [Abstract][Full Text] [Related]
4. The constitutively active Ah receptor (CA-Ahr) mouse as a potential model for dioxin exposure--effects in vital organs.
Brunnberg S; Andersson P; Lindstam M; Paulson I; Poellinger L; Hanberg A
Toxicology; 2006 Jul; 224(3):191-201. PubMed ID: 16766111
[TBL] [Abstract][Full Text] [Related]
5. Role of the aryl hydrocarbon receptor in the development of control and 2,3,7,8-tetrachlorodibenzo-p-dioxin-exposed male mice.
Lin TM; Ko K; Moore RW; Buchanan DL; Cooke PS; Peterson RE
J Toxicol Environ Health A; 2001 Oct; 64(4):327-42. PubMed ID: 11693491
[TBL] [Abstract][Full Text] [Related]
6. Aryl hydrocarbon receptor activation in genital tubercle, palate, and other embryonic tissues in 2,3,7, 8-tetrachlorodibenzo-p-dioxin-responsive lacZ mice.
Willey JJ; Stripp BR; Baggs RB; Gasiewicz TA
Toxicol Appl Pharmacol; 1998 Jul; 151(1):33-44. PubMed ID: 9705885
[TBL] [Abstract][Full Text] [Related]
7. Comparative contribution of the aryl hydrocarbon receptor gene to perinatal stage development and dioxin-induced toxicity between the urogenital complex and testis in the mouse.
Ohsako S; Fukuzawa N; Ishimura R; Kawakami T; Wu Q; Nagano R; Zaha H; Sone H; Yonemoto J; Tohyama C
Biol Reprod; 2010 Mar; 82(3):636-43. PubMed ID: 20007409
[TBL] [Abstract][Full Text] [Related]
8. Role of the aryl hydrocarbon receptor and Cyp1b1 in the antiestrogenic activity of 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Takemoto K; Nakajima M; Fujiki Y; Katoh M; Gonzalez FJ; Yokoi T
Arch Toxicol; 2004 Jun; 78(6):309-15. PubMed ID: 15004665
[TBL] [Abstract][Full Text] [Related]
9. Transgenic mouse lines expressing rat AH receptor variants--a new animal model for research on AH receptor function and dioxin toxicity mechanisms.
Pohjanvirta R
Toxicol Appl Pharmacol; 2009 Apr; 236(2):166-82. PubMed ID: 19371626
[TBL] [Abstract][Full Text] [Related]
10. In utero and lactational exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin: effects on development of the male and female reproductive system of the mouse.
Theobald HM; Peterson RE
Toxicol Appl Pharmacol; 1997 Jul; 145(1):124-35. PubMed ID: 9221831
[TBL] [Abstract][Full Text] [Related]
11. Antiestrogenic effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin in mouse uterus: critical role of the aryl hydrocarbon receptor in stromal tissue.
Buchanan DL; Sato T; Peterson RE; Cooke PS
Toxicol Sci; 2000 Oct; 57(2):302-11. PubMed ID: 11006360
[TBL] [Abstract][Full Text] [Related]
12. Aryl hydrocarbon receptors in urogenital sinus mesenchyme mediate the inhibition of prostatic epithelial bud formation by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Ko K; Moore RW; Peterson RE
Toxicol Appl Pharmacol; 2004 Apr; 196(1):149-55. PubMed ID: 15050416
[TBL] [Abstract][Full Text] [Related]
13. Ah receptor and ARNT protein and mRNA concentrations in rat prostate: effects of stage of development and 2,3,7, 8-tetrachlorodibenzo-p-dioxin treatment.
Sommer RJ; Sojka KM; Pollenz RS; Cooke PS; Peterson RE
Toxicol Appl Pharmacol; 1999 Mar; 155(2):177-89. PubMed ID: 10053172
[TBL] [Abstract][Full Text] [Related]
14. Conditional expression of a constitutively active aryl hydrocarbon receptor in MCF-7 human breast cancer cells.
Köhle C; Hassepass I; Bock-Hennig BS; Walter Bock K; Poellinger L; McGuire J
Arch Biochem Biophys; 2002 Jun; 402(2):172-9. PubMed ID: 12051661
[TBL] [Abstract][Full Text] [Related]
15. Aryl hydrocarbon receptor expression and activity in cerebellar granule neuroblasts: implications for development and dioxin neurotoxicity.
Williamson MA; Gasiewicz TA; Opanashuk LA
Toxicol Sci; 2005 Feb; 83(2):340-8. PubMed ID: 15537747
[TBL] [Abstract][Full Text] [Related]
16. Persistent, low-dose 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure: effect on aryl hydrocarbon receptor expression in a dioxin-resistance model.
Franc MA; Pohjanvirta R; Tuomisto J; Okey AB
Toxicol Appl Pharmacol; 2001 Aug; 175(1):43-53. PubMed ID: 11509025
[TBL] [Abstract][Full Text] [Related]
17. Pattern of male reproductive system effects after in utero and lactational 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) exposure in three differentially TCDD-sensitive rat lines.
Simanainen U; Haavisto T; Tuomisto JT; Paranko J; Toppari J; Tuomisto J; Peterson RE; Viluksela M
Toxicol Sci; 2004 Jul; 80(1):101-8. PubMed ID: 15084753
[TBL] [Abstract][Full Text] [Related]
18. Fetal exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin transactivates aryl hydrocarbon receptor-responsive element III in the tyrosine hydroxylase immunoreactive neurons of the mouse midbrain.
Tanida T; Tasaka K; Akahoshi E; Ishihara-Sugano M; Saito M; Kawata S; Danjo M; Tokumoto J; Mantani Y; Nagahara D; Tabuchi Y; Yokoyama T; Kitagawa H; Kawata M; Hoshi N
J Appl Toxicol; 2014 Feb; 34(2):117-26. PubMed ID: 23296914
[TBL] [Abstract][Full Text] [Related]
19. Transgenic mice with a constitutively active aryl hydrocarbon receptor display a gender-specific bone phenotype.
Wejheden C; Brunnberg S; Larsson S; Lind PM; Andersson G; Hanberg A
Toxicol Sci; 2010 Mar; 114(1):48-58. PubMed ID: 19934163
[TBL] [Abstract][Full Text] [Related]
20. Expression of constitutively-active aryl hydrocarbon receptor in T-cells enhances the down-regulation of CD62L, but does not alter expression of CD25 or suppress the allogeneic CTL response.
Funatake CJ; Ao K; Suzuki T; Murai H; Yamamoto M; Fujii-Kuriyama Y; Kerkvliet NI; Nohara K
J Immunotoxicol; 2009 Sep; 6(3):194-203. PubMed ID: 19635034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
